BridgeBio Pharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BBIO Nasdaq 2830 bridgebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BridgeBio Pharma, Inc.

BridgeBio Oncology and Helix enter definitive merger agreement - Mar 3rd, 2025 12:16 pm
Helix Acquisition to Merge With BridgeBio Oncology Therapeutics - Feb 28th, 2025 2:36 pm
BridgeBio oncology spinout to go public in blank-check merger - Feb 28th, 2025 11:50 am
BridgeBio Pharma (BBIO): Among the Best Performing Mid Cap Stocks to Buy According to Analysts - Feb 26th, 2025 4:56 pm
BridgeBio Prices Offering of $500 Million Convertible Senior Notes due 2031 to Refinance Senior Secured Debt - Feb 26th, 2025 7:49 am
BridgeBio Initiates Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes to Refinance Senior Secured Debt - Feb 24th, 2025 9:09 pm
Why BridgeBio Pharma, Inc. (BBIO) is the Best Performing Pharma Stock So Far in 2025 - Feb 23rd, 2025 8:07 pm
BridgeBio price target raised to $52 from $49 at Scotiabank - Feb 22nd, 2025 2:20 pm
BridgeBio Pharma (BBIO) Reports Q4 Loss, Tops Revenue Estimates - Feb 20th, 2025 1:55 pm
BridgeBio Pharma: Q4 Earnings Snapshot - Feb 20th, 2025 12:49 pm
BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update - Feb 20th, 2025 12:30 pm
BridgeBio’s heart drug launch gets off to a fast start - Feb 20th, 2025 10:53 am
BridgeBio Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on February 20, 2025 - Feb 13th, 2025 9:01 pm
BridgeBio price target raised to $49 from $48 at Scotiabank - Feb 13th, 2025 3:48 pm
EC grants marketing authorisation to BridgeBio’s ATTR-CM treatment - Feb 12th, 2025 11:40 am
BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM - Feb 11th, 2025 2:21 pm
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK - Feb 11th, 2025 11:38 am
Why BridgeBio Pharma, Inc. (BBIO) Is Among the Best Healthcare Stocks To Buy According to Analysts - Feb 8th, 2025 1:46 pm
DHT, Evolv Technologies, and More Stocks See Action From Activist Investors - Feb 8th, 2025 12:16 am
Why BridgeBio Pharma Inc. (BBIO) Crashed on Monday - Feb 4th, 2025 1:58 pm